1. P1081: PET-ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH-05 TRIAL. (23rd June 2022) Authors: Pavlovsky, A.; Fiad, N. L.; Prates, M. V.; Fernandez, I.; Kurgansky, N.; Cerutti, A.; Sackmann, F.; Negri Aranguren, F.; Negri Aranguren, P.; Remaggi, G.; Ferrari, L.; Mariano, R.; Guanchiale, L.; Maradei, J.; Giuliani, F.; Roveri, E.; Enrico, A.; Zabaljauregui, S.; Cabrejo, M. D. R.; Gumpel, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 971 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA. (23rd June 2022) Authors: Fiad, N. L.; Prates, M. V.; Fernandez, I.; Kurgansky, N.; Cerutti, A.; Negri Aranguren, F.; Guanchiale, L.; Sackmann, F.; Maradei, J.; Enrico, A.; Negri Aranguren, P.; Pavlovsky, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 972 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗